SANOFI

SAN
Real-time Quote. Real-time  - 01/25 06:36:45 am
81.6EUR +0.17%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:
- pharmaceutical products (84.1%): for the treatment of cardio-vascular diseases, thrombosis, central nervous system disorders (insomnia, multiple sclerosis, epilepsy), cancers, allergies, etc. Moreover, Sanofi-Aventis markets OTC products and generic drugs;
- human vaccines (15.9%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas.
At the end of 2019, the group had 81 production sites throughout the world.
Net sales are distributed geographically as follows: Europe (24.5%), United States (35.3%), Asia (12.2%), Latin America (7.6%), Africa and Middle East (6.4%) and other (14%).

Number of employees : 100 409 people.
Sales per Business
20182019
EUR
(in Million)
%EUR
(in Million)
%
Pharmaceuticals 24,68571.6% 25,70871.2%
Vaccines 5,11814.9% 5,73115.9%
Consumer Healthcare 4,66013.5% 4,68713%
Sales per region
2019
EUR
(in Million)
%
United States 12,75635.3%
Europe 6,59118.2%
Asia 4,39312.2%
Latin America 2,7347.6%
Africa and Middle East 2,3076.4%
France 2,2616.3%
Japan 1,9085.3%
Eurasia 1,3123.6%
Rest of the World 1,2473.5%
South Korea 449.001.2%
Managers
Name Title
Paul Hudson Chief Executive Officer & Director
Serge Weinberg Chairman
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Dietmar P. Berger Chief Medical Officer & Global Head-Development
Carole Piwnica Independent Director
Laurent Attal Director
Fabienne Lecorvaisier Independent Director
Patrick Kron Independent Director
Shareholders
Name Equities %
L'Oréal S.A. 118,227,307 9.39%
The Vanguard Group, Inc. 28,643,834 2.28%
Norges Bank Investment Management 26,690,482 2.12%
Plan d'Epargne Entreprise Sanofi Synthelabo 20,371,851 1.62%
Fidelity Management & Research Co. LLC 19,885,289 1.58%
Dodge & Cox 15,363,609 1.22%
Amundi Asset Management SA (Investment Management) 13,921,917 1.11%
Lyxor International Asset Management SAS 12,412,661 0.99%
BNP Paribas Asset Management France SAS 10,522,282 0.84%
BlackRock Advisors (UK) Ltd. 10,063,468 0.80%
Company contact information
54 Rue la Boétie
FR-75008 Paris


Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
web site : http://www.sanofi.com
Markets and indexes
-
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, Euro Stoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, SBF 120, Stoxx Europe 50, STOXX Europe 600, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
SANOFI2.26%124 582
JOHNSON & JOHNSON3.92%430 552
ROCHE HOLDING AG3.06%308 615
NOVARTIS AG2.73%220 726
MERCK & CO., INC.-1.00%204 882
PFIZER INC.-0.71%203 159
ABBVIE INC.3.46%195 720
ELI LILLY AND COMPANY22.09%186 883
NOVO NORDISK A/S4.18%168 128
AMGEN INC.10.26%147 580
BRISTOL-MYERS SQUIBB COMPANY4.08%145 890
ASTRAZENECA PLC6.19%139 483
SANOFI3.51%124 582
GLAXOSMITHKLINE PLC2.85%94 107
JIANGSU HENGRUI MEDICINE CO., LTD.1.02%92 231
CHUGAI PHARMACEUTICAL CO., LTD.2.11%88 992
DAIICHI SANKYO COMPANY, LIMITED1.27%66 704
BAYER AG8.73%62 617
TAKEDA PHARMACEUTICAL COMPANY LIMITED-4.47%54 029
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED20.88%34 701
ASTELLAS PHARMA INC.5.71%30 155
Brand Portfolio
SANOFI
SANOFI
ABLYNX
ABLYNX
ACT
ACT
ALLSTAR
ALLSTAR
BIOVERATIV
BIOVERATIV
CEPIA
CEPIA
FRONTLINE
FRONTLINE
MERIAL
MERIAL
PLAQUENIL
PLAQUENIL
PRINCIPIA BIOPHARMA
PRINCIPIA BIOPHARMA
QUENSYL
QUENSYL
SANOFI-AVENTIS
SANOFI-AVENTIS
SYNTHORX
SYNTHORX
» More brands of Sanofi